Mark Carol, MD, Receives Ira Sohn Conference Foundation Prize in Pediatric Oncology for Novel Approaches for Using X-ray Based Radiation Therapy to
Treat Cancer Patients
SUNNYVALE, Calif., April 3, 2008 /PRNewswire/ -- Xoft consulting medical director, Mark Carol, MD, has received the Ira Sohn Conference Foundation Prize in Pediatric Oncology for his research focused on novel approaches for using KV X-ray-based radiation therapy to treat patients with cancer.
According to Dr. Carol, Xoft's Axxent(R) Electronic Brachytherapy System, a proprietary technology platform designed to deliver localized, non- radioactive, isotope-free radiation treatment in minimally-shielded clinical settings, was the inspiration for his work that was recognized by the Gotham Prize for Cancer Research.
"After having spent more than 20 years in radiation oncology, I believe that without significant and dramatic new approaches to solve ongoing problems in cancer treatment, we will only see incremental advances to patient care," said Dr. Carol. "My first exposure to Xoft's internally delivered KV X-rays encouraged me to explore novel approaches to KV radiation delivery that might lead to such fundamental breakthroughs in cancer research and treatment. The work recognized by the Gotham Prize involves a technique for delivering external beam KV X-rays in such a way that they can attain therapeutic levels deeper in tissue, and selectively in cancer cells versus normal cells, than has been previously possible."
The Gotham Prize was launched in 2007 by hedge fund managers Joel
Greenblatt and Robert Goldstein of private investment firm Gotham Capital,
and respected medical researcher Dr. Gary Curhan of Harvard Medical School,
with support from the Ira Sohn Conference Foundation and Ephraim Gildor of
Axiom Investment Advisors. Inspired by the memory of Goldstein's mother,
Hope Goldstein, who passed away from ovarian cancer, the founders s
|SOURCE Xoft, Inc.|
Copyright©2008 PR Newswire.
All rights reserved